BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19051724)

  • 1. [Pulmonary arterial hypertension and BMP system abnormality].
    Otsuka F
    Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
    Morrell NW
    Proc Am Thorac Soc; 2006 Nov; 3(8):680-6. PubMed ID: 17065373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
    Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
    Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.
    Jurasz P; Courtman D; Babaie S; Stewart DJ
    Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.
    West J; Fagan K; Steudel W; Fouty B; Lane K; Harral J; Hoedt-Miller M; Tada Y; Ozimek J; Tuder R; Rodman DM
    Circ Res; 2004 Apr; 94(8):1109-14. PubMed ID: 15031260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics and physiopathology of primary or secondary pulmonary artery hypertension].
    Adnot S; Eddahibi S
    Bull Acad Natl Med; 2003; 187(8):1529-42; discussion 1543-5. PubMed ID: 15146583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: remodeling revisited.
    Eickelberg O; Morty RE
    Trends Cardiovasc Med; 2007 Nov; 17(8):263-9. PubMed ID: 18021936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of injuries pulmonary arterial endothelial cell induced by endotoxin on proliferation of pulmonary artery smooth muscle cells and interference effect of bone morphogenetic protein-2].
    Pei L; Shan SM; Sun XY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):40-5. PubMed ID: 18346379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenic protein-9 stimulates endothelin-1 release from human pulmonary microvascular endothelial cells: a potential mechanism for elevated ET-1 levels in pulmonary arterial hypertension.
    Star GP; Giovinazzo M; Langleben D
    Microvasc Res; 2010 Dec; 80(3):349-54. PubMed ID: 20594999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
    Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma?
    Stewart DJ
    Circ Res; 2005 May; 96(10):1033-5. PubMed ID: 15920025
    [No Abstract]   [Full Text] [Related]  

  • 18. Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications.
    Michelakis ED
    Circ Res; 2006 Feb; 98(2):172-5. PubMed ID: 16456109
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.
    Girerd B; Coulet F; Jaïs X; Eyries M; Van Der Bruggen C; De Man F; Houweling A; Dorfmüller P; Savale L; Sitbon O; Vonk-Noordegraaf A; Soubrier F; Simonneau G; Humbert M; Montani D
    Chest; 2015 May; 147(5):1385-1394. PubMed ID: 25429696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in BMP receptor signaling.
    Sieber C; Kopf J; Hiepen C; Knaus P
    Cytokine Growth Factor Rev; 2009; 20(5-6):343-55. PubMed ID: 19897402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.